[
  {
    "title": "红日药业(300026.SZ)：姚小青减持量过半 累计减持1543.99万股",
    "href": "http://stock.jrj.com.cn/2022/12/12165437206120.shtml",
    "datetime": "2022-12-12 16:54:29",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：持股5%以上股东姚小青累计减持1.0086%股份",
    "href": "http://stock.jrj.com.cn/2022/11/30164937178389.shtml",
    "datetime": "2022-11-30 16:49:22",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)甲苯磺酰胺原料药获批 参股子公司甲苯磺酰胺注射液取得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/21180237154952.shtml",
    "datetime": "2022-11-21 18:02:21",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：控股股东拟参与转融通证券出借业务、出借不超1%股份",
    "href": "http://stock.jrj.com.cn/2022/11/10164637127850.shtml",
    "datetime": "2022-11-10 16:46:01",
    "code": "300026"
  },
  {
    "title": "红日药业2022年前三季度净利4.7亿同比下滑26.15% 本期研发投入增加",
    "href": "http://stock.jrj.com.cn/2022/10/24181137078696.shtml",
    "datetime": "2022-10-24 18:11:52",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：注射用胸腺法新获批上市",
    "href": "http://stock.jrj.com.cn/2022/07/05160036783607.shtml",
    "datetime": "2022-07-05 16:00:11",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：股东姚小青减持量过半 累计减持0.5584%股份",
    "href": "http://stock.jrj.com.cn/2022/06/21155136746246.shtml",
    "datetime": "2022-06-21 15:51:19",
    "code": "300026"
  },
  {
    "title": "红日药业：股东大通投资所持1770万股被轮候冻结",
    "href": "http://stock.jrj.com.cn/2022/06/17172736738617.shtml",
    "datetime": "2022-06-17 17:27:02",
    "code": "300026"
  },
  {
    "title": "红日药业：股东姚小青累计减持约3289.94万股 占公司总股本比例1.10%",
    "href": "http://stock.jrj.com.cn/2022/06/09103336715016.shtml",
    "datetime": "2022-06-09 10:33:37",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：持股5%以上股东姚小青累计减持1.1%股份",
    "href": "http://stock.jrj.com.cn/2022/06/08204136713842.shtml",
    "datetime": "2022-06-08 20:41:25",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：持股12.7251%股东姚小青拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2022/05/13160636646522.shtml",
    "datetime": "2022-05-13 16:06:56",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)2021年度权益分派10派0.4元 股权登记日为5月18日",
    "href": "http://stock.jrj.com.cn/2022/05/11175636634802.shtml",
    "datetime": "2022-05-11 17:56:46",
    "code": "300026"
  },
  {
    "title": "红日药业2022年第一季度净利2.38亿同比增长23.34% 政府补助增加",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546539.shtml",
    "datetime": "2022-05-03 19:11:52",
    "code": "300026"
  },
  {
    "title": "红日药业2021年净利6.87亿同比增长19.87% 董事长姚小青薪酬280.93万",
    "href": "http://stock.jrj.com.cn/2022/03/30221036208446.shtml",
    "datetime": "2022-03-30 22:10:52",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：2021年度净利升19.87%至6.87亿元 拟10派0.4元",
    "href": "http://stock.jrj.com.cn/2022/03/30165536197977.shtml",
    "datetime": "2022-03-30 16:55:19",
    "code": "300026"
  },
  {
    "title": "【龙虎榜】红日药业3月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/21180334856590.shtml",
    "datetime": "2022-03-21 18:03:51",
    "code": "300026"
  },
  {
    "title": "红日药业涨幅超10.80%，中药基金LOF（501011）涨超2.02%",
    "href": "http://stock.jrj.com.cn/2022/03/21151134855543.shtml",
    "datetime": "2022-03-21 15:11:13",
    "code": "300026"
  },
  {
    "title": "A股异动 | 红日药业(300026.SZ)涨超11% 全资子公司北京康仁堂通过TGA认证检查",
    "href": "http://stock.jrj.com.cn/2022/03/21145534855451.shtml",
    "datetime": "2022-03-21 14:55:47",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134866795.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134870993.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134872326.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134855432.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134865488.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134868175.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司通过澳大利亚TGA-GMP认证 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2022/03/21135134869556.shtml",
    "datetime": "2022-03-21 13:51:53",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：全资子公司北京康仁堂通过TGA认证检查",
    "href": "http://stock.jrj.com.cn/2022/03/21115034854898.shtml",
    "datetime": "2022-03-21 11:50:05",
    "code": "300026"
  },
  {
    "title": "【龙虎榜】红日药业3月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/17180134840053.shtml",
    "datetime": "2022-03-17 18:01:06",
    "code": "300026"
  },
  {
    "title": "红日药业涨幅超20.06%，中药基金LOF（501011）涨超3.47%",
    "href": "http://stock.jrj.com.cn/2022/03/17153134839074.shtml",
    "datetime": "2022-03-17 15:31:58",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：血必净注射液列入《新型冠状病毒肺炎诊疗方案(试行第九版)》",
    "href": "http://stock.jrj.com.cn/2022/03/16155134834242.shtml",
    "datetime": "2022-03-16 15:51:34",
    "code": "300026"
  },
  {
    "title": "红日药业2021年净利6.88亿同比增长20.03% 血必净注射液销售量稳步增长",
    "href": "http://stock.jrj.com.cn/2022/02/28145134496530.shtml",
    "datetime": "2022-02-28 14:51:32",
    "code": "300026"
  },
  {
    "title": "红日药业业绩快报：加强资源配置和业务协同 2021年净利同比增长两成",
    "href": "http://stock.jrj.com.cn/2022/02/28141334496518.shtml",
    "datetime": "2022-02-28 14:13:25",
    "code": "300026"
  },
  {
    "title": "红日药业2021年预计净利6.31亿-7.46亿同比增长10%-30% 主力产品销量稳步增长",
    "href": "http://stock.jrj.com.cn/2022/01/28193134246133.shtml",
    "datetime": "2022-01-28 19:31:48",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：2021年度净利预增10.05%-30.10%",
    "href": "http://stock.jrj.com.cn/2022/01/28165334243203.shtml",
    "datetime": "2022-01-28 16:53:45",
    "code": "300026"
  },
  {
    "title": "红日药业：公司与302医院联合研发“克冠一号”产品 目前正处在科研阶段",
    "href": "http://stock.jrj.com.cn/2022/01/18143934169448.shtml",
    "datetime": "2022-01-18 14:39:12",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：依诺肝素钠注射获批上市",
    "href": "http://stock.jrj.com.cn/2022/01/11160834146155.shtml",
    "datetime": "2022-01-11 16:08:12",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：部分董事、高管已合计减持174.27万股",
    "href": "http://stock.jrj.com.cn/2022/01/07162734133708.shtml",
    "datetime": "2022-01-07 16:27:13",
    "code": "300026"
  },
  {
    "title": "【龙虎榜】红日药业1月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/06180334130289.shtml",
    "datetime": "2022-01-06 18:03:52",
    "code": "300026"
  },
  {
    "title": "【龙虎榜】红日药业12月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/27180434071644.shtml",
    "datetime": "2021-12-27 18:04:14",
    "code": "300026"
  },
  {
    "title": "【龙虎榜】红日药业12月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/24180434058832.shtml",
    "datetime": "2021-12-24 18:04:12",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：罗库溴铵注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/12/09164133990295.shtml",
    "datetime": "2021-12-09 16:41:49",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：血必净注射液继续纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03115233959411.shtml",
    "datetime": "2021-12-03 11:52:41",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：第三季度净利降21.98%至1.99亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28161033769115.shtml",
    "datetime": "2021-10-28 16:10:13",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：KB项目获得美国FDA临床试验资格",
    "href": "http://stock.jrj.com.cn/2021/10/19162533716668.shtml",
    "datetime": "2021-10-19 16:25:51",
    "code": "300026"
  },
  {
    "title": "红日药业2021年前三季度预计净利5.99亿元–7.19亿元 比上年同期增加0%–20%",
    "href": "http://stock.jrj.com.cn/2021/10/14232933696165.shtml",
    "datetime": "2021-10-14 23:29:38",
    "code": "300026"
  },
  {
    "title": "红日药业5名股东合计减持233万股 套现合计1099.76万 上半年公司净利4.38亿",
    "href": "http://stock.jrj.com.cn/2021/09/07213233400255.shtml",
    "datetime": "2021-09-07 21:32:00",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：部分董事、高管已通过大宗交易减持233万股",
    "href": "http://stock.jrj.com.cn/2021/09/07170133398919.shtml",
    "datetime": "2021-09-07 17:01:12",
    "code": "300026"
  },
  {
    "title": "红日药业2021年半年度净利4.38亿元 同比净利增加27.37%",
    "href": "http://stock.jrj.com.cn/2021/08/27182333334639.shtml",
    "datetime": "2021-08-27 18:23:47",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：拟公开发行不超6亿元公司债券",
    "href": "http://stock.jrj.com.cn/2021/08/12211533244826.shtml",
    "datetime": "2021-08-12 21:15:46",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：盐酸普拉克索缓释片获批上市",
    "href": "http://stock.jrj.com.cn/2021/08/02115833188002.shtml",
    "datetime": "2021-08-02 11:58:18",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：盐酸普拉克索片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/07/20175433125049.shtml",
    "datetime": "2021-07-20 17:54:10",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持约28.52万股被轮候冻结",
    "href": "http://stock.jrj.com.cn/2021/07/16170233108078.shtml",
    "datetime": "2021-07-16 17:02:23",
    "code": "300026"
  },
  {
    "title": "红日药业2021年上半年预计净利4.13亿-5.16亿增长20%-50% 医疗器械板块销量增长",
    "href": "http://stock.jrj.com.cn/2021/07/14183633095872.shtml",
    "datetime": "2021-07-14 18:36:23",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)上半年预盈4.13亿元-5.16亿元 同比增长20%-50%",
    "href": "http://stock.jrj.com.cn/2021/07/14115233094035.shtml",
    "datetime": "2021-07-14 11:52:42",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持公司股份被轮候冻结4025.2928万股",
    "href": "http://stock.jrj.com.cn/2021/07/09180233070716.shtml",
    "datetime": "2021-07-09 18:02:01",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)获准发行不超12亿元公司债",
    "href": "http://stock.jrj.com.cn/2021/06/24160132989808.shtml",
    "datetime": "2021-06-24 16:01:53",
    "code": "300026"
  },
  {
    "title": "红日药业销售违反防疫要求引风波 应收款大增三成暗藏隐忧",
    "href": "http://stock.jrj.com.cn/2021/06/18075232952073.shtml",
    "datetime": "2021-06-18 07:52:17",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持公司股份被轮候冻结1045.5786万股",
    "href": "http://stock.jrj.com.cn/2021/06/17170432948223.shtml",
    "datetime": "2021-06-17 17:04:01",
    "code": "300026"
  },
  {
    "title": "红日药业：公司在山东省济南市商河县建设中药配方颗粒生产基地项目已于6月7日进行了基地奠基仪式",
    "href": "http://stock.jrj.com.cn/2021/06/17140232947169.shtml",
    "datetime": "2021-06-17 14:02:07",
    "code": "300026"
  },
  {
    "title": "红日药业：公司在今年的3月底前就已完成了山东红日康仁堂药业有限公司的工商注册与团队组建",
    "href": "http://stock.jrj.com.cn/2021/06/17135432947096.shtml",
    "datetime": "2021-06-17 13:54:13",
    "code": "300026"
  },
  {
    "title": "红日药业：公司暂无该医用抗生素产品",
    "href": "http://stock.jrj.com.cn/2021/06/17135132947088.shtml",
    "datetime": "2021-06-17 13:51:27",
    "code": "300026"
  },
  {
    "title": "红日药业：公司在研项目KB项目正在做二期临床",
    "href": "http://stock.jrj.com.cn/2021/06/17104932946255.shtml",
    "datetime": "2021-06-17 10:49:36",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：1382.50万股限制性股票待解锁 可上市流通数量为827.50万股",
    "href": "http://stock.jrj.com.cn/2021/06/16182732941726.shtml",
    "datetime": "2021-06-16 18:27:50",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持公司部分股份被轮候冻结",
    "href": "http://stock.jrj.com.cn/2021/06/10174032906016.shtml",
    "datetime": "2021-06-10 17:40:35",
    "code": "300026"
  },
  {
    "title": "红日药业：公司在研产品PD-L1正在开展一期临床试验工作",
    "href": "http://stock.jrj.com.cn/2021/06/09141832899400.shtml",
    "datetime": "2021-06-09 14:18:09",
    "code": "300026"
  },
  {
    "title": "红日药业：公司暂没有抗毛霉菌的药品",
    "href": "http://stock.jrj.com.cn/2021/06/09141032899370.shtml",
    "datetime": "2021-06-09 14:10:43",
    "code": "300026"
  },
  {
    "title": "红日药业：PTS项目发补资料已提交 等待国家局审评交",
    "href": "http://stock.jrj.com.cn/2021/06/09134532899241.shtml",
    "datetime": "2021-06-09 13:45:40",
    "code": "300026"
  },
  {
    "title": "红日药业：公司已经把血必净注射液向FDA提交了申请",
    "href": "http://stock.jrj.com.cn/2021/06/09133732899204.shtml",
    "datetime": "2021-06-09 13:37:08",
    "code": "300026"
  },
  {
    "title": "红日药业：盐酸沙格雷酯片获得药品注册批件 有助于提升公司产品市场竞争力",
    "href": "http://stock.jrj.com.cn/2021/06/02145132863143.shtml",
    "datetime": "2021-06-02 14:51:43",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：盐酸沙格雷酯片国内首家获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/02114832862247.shtml",
    "datetime": "2021-06-02 11:48:08",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：盐酸法舒地尔注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/11171032736100.shtml",
    "datetime": "2021-05-11 17:10:05",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净注射液是公司主力产品之一",
    "href": "http://stock.jrj.com.cn/2021/04/30140932486738.shtml",
    "datetime": "2021-04-30 14:09:44",
    "code": "300026"
  },
  {
    "title": "红日药业：公司正处于2021年第一季度报告编制阶段 按照相关规定暂时不方便接待机构调研",
    "href": "http://stock.jrj.com.cn/2021/04/21140832415810.shtml",
    "datetime": "2021-04-21 14:08:31",
    "code": "300026"
  },
  {
    "title": "红日药业：大通投资冻结是股东的问题 公司生产经营一切正常",
    "href": "http://stock.jrj.com.cn/2021/04/21140332415817.shtml",
    "datetime": "2021-04-21 14:03:34",
    "code": "300026"
  },
  {
    "title": "红日药业：四季度管理费用主要是研发投入、信息化建设投入和管理人员年度绩效影响到管理费用的上升",
    "href": "http://stock.jrj.com.cn/2021/04/21135932415792.shtml",
    "datetime": "2021-04-21 13:59:16",
    "code": "300026"
  },
  {
    "title": "红日药业：公司控股股东兴城集团持有公司22.24%股权",
    "href": "http://stock.jrj.com.cn/2021/04/08102632330607.shtml",
    "datetime": "2021-04-08 10:26:24",
    "code": "300026"
  },
  {
    "title": "红日药业：公司持股5%以上的股东大通集团因合同纠纷被法院冻结了其持有的本公司部分股份",
    "href": "http://stock.jrj.com.cn/2021/04/08101932330560.shtml",
    "datetime": "2021-04-08 10:19:35",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净注射液可以在全国各省市医院临床使用",
    "href": "http://stock.jrj.com.cn/2021/04/08101732330559.shtml",
    "datetime": "2021-04-08 10:17:34",
    "code": "300026"
  },
  {
    "title": "红日药业：公司申报的注射用甲磺酸苦柯胺B（简称“KB”）符合药品注册的有关要求",
    "href": "http://stock.jrj.com.cn/2021/04/08100532330481.shtml",
    "datetime": "2021-04-08 10:05:17",
    "code": "300026"
  },
  {
    "title": "红日药业：公司2021年第一季度报告将于2021年4月28日披露",
    "href": "http://stock.jrj.com.cn/2021/04/08095132330356.shtml",
    "datetime": "2021-04-08 09:51:37",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持公司股份被司法再冻结749.5805万股",
    "href": "http://stock.jrj.com.cn/2021/04/02174832271318.shtml",
    "datetime": "2021-04-02 17:48:22",
    "code": "300026"
  },
  {
    "title": "红日药业2021年第一季度预计净利增长60%-90% 加强成本费用控制",
    "href": "http://stock.jrj.com.cn/2021/03/31233032259153.shtml",
    "datetime": "2021-03-31 23:30:20",
    "code": "300026"
  },
  {
    "title": "红日药业2020年净利增长42.45% 医疗器械业务增长",
    "href": "http://stock.jrj.com.cn/2021/03/31223132258837.shtml",
    "datetime": "2021-03-31 22:31:39",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)一季度净利润预增60%-90%",
    "href": "http://stock.jrj.com.cn/2021/03/31154232256006.shtml",
    "datetime": "2021-03-31 15:42:37",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)2020年度净利润升42.45%至5.73亿元 拟10派0.4元",
    "href": "http://stock.jrj.com.cn/2021/03/31154032255994.shtml",
    "datetime": "2021-03-31 15:40:59",
    "code": "300026"
  },
  {
    "title": "红日药业：公司年审工作正在进行中",
    "href": "http://stock.jrj.com.cn/2021/03/24150132208368.shtml",
    "datetime": "2021-03-24 15:01:53",
    "code": "300026"
  },
  {
    "title": "红日药业：公司正在准备血必净注射液的海外拓展相关工作",
    "href": "http://stock.jrj.com.cn/2021/03/02130532056563.shtml",
    "datetime": "2021-03-02 13:05:24",
    "code": "300026"
  },
  {
    "title": "红日药业2020年度净利5.76亿增长42.99% 医疗器械产品国外订单量大幅增长",
    "href": "http://stock.jrj.com.cn/2021/02/25212332027969.shtml",
    "datetime": "2021-02-25 21:23:36",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：持股5%以上的大通集团所持股份被司法再冻结352.5435万股",
    "href": "http://stock.jrj.com.cn/2021/02/25173232026346.shtml",
    "datetime": "2021-02-25 17:32:07",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)业绩快报：2020年度净利润升42.99%至5.76亿元",
    "href": "http://stock.jrj.com.cn/2021/02/25173032026325.shtml",
    "datetime": "2021-02-25 17:30:05",
    "code": "300026"
  },
  {
    "title": "红日药业：一类新药PTS项目正在进行国家药品监督管理局药审中心的第二次发补的研究和讨论",
    "href": "http://stock.jrj.com.cn/2021/02/22101932004801.shtml",
    "datetime": "2021-02-22 10:19:51",
    "code": "300026"
  },
  {
    "title": "红日药业股东大通集团减持4896.35万股 套现2.57亿",
    "href": "http://stock.jrj.com.cn/2021/02/05205531856360.shtml",
    "datetime": "2021-02-05 20:55:19",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团减持完成 累计减持4896.35万股",
    "href": "http://stock.jrj.com.cn/2021/02/05165531855103.shtml",
    "datetime": "2021-02-05 16:55:24",
    "code": "300026"
  },
  {
    "title": "红日药业2020年预计净利5.23亿-6.04亿增长30%-50% 医疗器械板块订单量增长",
    "href": "http://stock.jrj.com.cn/2021/01/27221531793840.shtml",
    "datetime": "2021-01-27 22:15:51",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：股东大通集团解除质押1000万股",
    "href": "http://stock.jrj.com.cn/2021/01/19164531722239.shtml",
    "datetime": "2021-01-19 16:45:45",
    "code": "300026"
  },
  {
    "title": "湖北辰美中药违法生产销售假药遭罚 为红日药业孙公司",
    "href": "http://stock.jrj.com.cn/2021/01/13091331681222.shtml",
    "datetime": "2021-01-13 09:13:00",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持有公司部分股份被司法冻结44.306万股",
    "href": "http://stock.jrj.com.cn/2021/01/04163931627442.shtml",
    "datetime": "2021-01-04 16:39:59",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团累计减持3424.11万股 减持数量已过半",
    "href": "http://stock.jrj.com.cn/2020/12/25191731571828.shtml",
    "datetime": "2020-12-25 19:17:04",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团解除质押1000万股",
    "href": "http://stock.jrj.com.cn/2020/12/24170031562053.shtml",
    "datetime": "2020-12-24 17:00:25",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：股东大通集团所持334.7705万股被司法冻结",
    "href": "http://stock.jrj.com.cn/2020/12/23194231555502.shtml",
    "datetime": "2020-12-23 19:42:21",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持公司股份被司法冻结16.9265万股",
    "href": "http://stock.jrj.com.cn/2020/12/16170531502866.shtml",
    "datetime": "2020-12-16 17:05:19",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团所持4921万股解除司法冻结及4040万股被再冻结",
    "href": "http://stock.jrj.com.cn/2020/12/08171431441068.shtml",
    "datetime": "2020-12-08 17:14:53",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：大通集团减持期过半 累计减持3900.11万股",
    "href": "http://stock.jrj.com.cn/2020/11/03171431209082.shtml",
    "datetime": "2020-11-03 17:14:50",
    "code": "300026"
  },
  {
    "title": "红日药业2020年前三季度净利5.99亿增长16.05% 医疗器械海外销售增加",
    "href": "http://stock.jrj.com.cn/2020/10/30210631177004.shtml",
    "datetime": "2020-10-30 21:06:43",
    "code": "300026"
  },
  {
    "title": "红日药业：大通集团所持1.31亿股被司法冻结",
    "href": "http://stock.jrj.com.cn/2020/10/21073531097610.shtml",
    "datetime": "2020-10-21 07:35:00",
    "code": "300026"
  },
  {
    "title": "红日药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15081231057171.shtml",
    "datetime": "2020-10-15 08:12:09",
    "code": "300026"
  },
  {
    "title": "红日药业2020年前三季度净利5.42亿至6.45亿 公司医疗器械板块国外订单量较同期增长迅速",
    "href": "http://stock.jrj.com.cn/2020/10/14233331054579.shtml",
    "datetime": "2020-10-14 23:33:00",
    "code": "300026"
  },
  {
    "title": "红日药业：大通集团近期合计减持6526.24万股 占公司总股本2.1724%",
    "href": "http://stock.jrj.com.cn/2020/09/23144030817363.shtml",
    "datetime": "2020-09-23 14:40:33",
    "code": "300026"
  },
  {
    "title": "红日药业(300026.SZ)：股东大通集团减持比例达2.1724%",
    "href": "http://stock.jrj.com.cn/2020/09/23115530816354.shtml",
    "datetime": "2020-09-23 11:55:24",
    "code": "300026"
  },
  {
    "title": "甘肃检查15家医疗器械企业 红日药业旗下公司遭整改",
    "href": "http://stock.jrj.com.cn/2020/09/17174830770672.shtml",
    "datetime": "2020-09-17 17:48:00",
    "code": "300026"
  },
  {
    "title": "《股东来了》2020天津片区走进上市公司第二站：红日药业",
    "href": "http://stock.jrj.com.cn/2020/09/04175930678020.shtml",
    "datetime": "2020-09-04 17:59:24",
    "code": "300026"
  },
  {
    "title": "红日药业控股股东兴城集团收监管函 权益变动信披违规",
    "href": "http://stock.jrj.com.cn/2020/09/03154630668652.shtml",
    "datetime": "2020-09-03 15:46:00",
    "code": "300026"
  },
  {
    "title": "红日药业2020年上半年净利3.44亿下滑1.86% 营业成本同比增长",
    "href": "http://stock.jrj.com.cn/2020/08/25145530585740.shtml",
    "datetime": "2020-08-25 14:55:01",
    "code": "300026"
  },
  {
    "title": "红日药业：盐酸莫西沙星氯化钠注射液中标第三批国家药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/08/20172030550377.shtml",
    "datetime": "2020-08-20 17:20:15",
    "code": "300026"
  },
  {
    "title": "中标莫西沙星氯化钠注射剂 红日药业：价格最后给到了最低",
    "href": "http://stock.jrj.com.cn/2020/08/20123430548375.shtml",
    "datetime": "2020-08-20 12:34:10",
    "code": "300026"
  },
  {
    "title": "红日药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15084030245922.shtml",
    "datetime": "2020-07-15 08:40:02",
    "code": "300026"
  },
  {
    "title": "红日药业2020年上半年预计净利3.15亿元-3.85亿元 疫情用药销售量增长",
    "href": "http://stock.jrj.com.cn/2020/07/15001630242399.shtml",
    "datetime": "2020-07-15 00:16:57",
    "code": "300026"
  },
  {
    "title": "红日药业：股东大通集团拟减持不超过总股本2%",
    "href": "http://stock.jrj.com.cn/2020/07/13181430226909.shtml",
    "datetime": "2020-07-13 18:14:58",
    "code": "300026"
  },
  {
    "title": "红日药业副总经理QIAN XIAOLUN辞职 2019年薪酬为250.17万元",
    "href": "http://stock.jrj.com.cn/2020/07/02192530124662.shtml",
    "datetime": "2020-07-02 19:25:08",
    "code": "300026"
  },
  {
    "title": "红日药业3名股东合计减持216.36万股 套现约1263.54万元",
    "href": "http://stock.jrj.com.cn/2020/06/17200529951255.shtml",
    "datetime": "2020-06-17 20:05:32",
    "code": "300026"
  },
  {
    "title": "红日药业：高管高国伟因家属误操作致违规减持10万股",
    "href": "http://stock.jrj.com.cn/2020/06/04173329845316.shtml",
    "datetime": "2020-06-04 17:33:59",
    "code": "300026"
  },
  {
    "title": "红日药业：获得一项药品注册批件 有利于提升公司在骨科疾病用药市场竞争力",
    "href": "http://stock.jrj.com.cn/2020/05/13164129661535.shtml",
    "datetime": "2020-05-13 16:41:37",
    "code": "300026"
  },
  {
    "title": "暴涨后又暴跌！ 红日药业净利润翻倍恐难持续",
    "href": "http://stock.jrj.com.cn/2020/04/29082529608438.shtml",
    "datetime": "2020-04-29 08:25:00",
    "code": "300026"
  },
  {
    "title": "红日药业第一季度盈利1.09亿同比下滑37.65% 营业成本同比增长",
    "href": "http://stock.jrj.com.cn/2020/04/28204829407674.shtml",
    "datetime": "2020-04-28 20:48:12",
    "code": "300026"
  },
  {
    "title": "红日药业2019年净利4.03亿增长90.96% 各项经营指标均按计划达成",
    "href": "http://stock.jrj.com.cn/2020/04/27234829398899.shtml",
    "datetime": "2020-04-27 23:48:22",
    "code": "300026"
  },
  {
    "title": "红日药业收关注函：说明血必净注射液新增适应症获得申请批件对公司未来业绩影响",
    "href": "http://stock.jrj.com.cn/2020/04/17204329315559.shtml",
    "datetime": "2020-04-17 20:43:18",
    "code": "300026"
  },
  {
    "title": "红日药业：获天津市科学技术进步一等奖",
    "href": "http://stock.jrj.com.cn/2020/04/17180729314741.shtml",
    "datetime": "2020-04-17 18:07:00",
    "code": "300026"
  },
  {
    "title": "红日药业：获得天津市科学技术进步一等奖",
    "href": "http://stock.jrj.com.cn/2020/04/16194829306891.shtml",
    "datetime": "2020-04-16 19:48:00",
    "code": "300026"
  },
  {
    "title": "血必净获批用于重型、危重型新冠肺炎 红日药业涨停封单近170万手",
    "href": "http://stock.jrj.com.cn/2020/04/15095129293808.shtml",
    "datetime": "2020-04-15 09:51:33",
    "code": "300026"
  },
  {
    "title": "中西医护航：硫酸羟氯喹或用于治疗新冠肺炎 红日药业血必净获批用于重型、危重型新冠肺炎",
    "href": "http://stock.jrj.com.cn/2020/04/14225629286915.shtml",
    "datetime": "2020-04-14 22:56:07",
    "code": "300026"
  },
  {
    "title": "红日药业：公司产品血必净注射液新增适应症获得申请批件",
    "href": "http://stock.jrj.com.cn/2020/04/14175429285026.shtml",
    "datetime": "2020-04-14 17:54:13",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净注射液获批新冠肺炎重型、危重型治疗",
    "href": "http://stock.jrj.com.cn/2020/04/14174129284820.shtml",
    "datetime": "2020-04-14 17:41:00",
    "code": "300026"
  },
  {
    "title": "红日药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10084029253779.shtml",
    "datetime": "2020-04-10 08:40:17",
    "code": "300026"
  },
  {
    "title": "红日药业2020年第一季度预计净利9644.01万元-1.32亿元 同比下降25%-45%",
    "href": "http://stock.jrj.com.cn/2020/04/10072429253192.shtml",
    "datetime": "2020-04-10 07:24:56",
    "code": "300026"
  },
  {
    "title": "红日药业：一季度血必净注射液销售量同比大幅增长 收入同比持平",
    "href": "http://stock.jrj.com.cn/2020/04/09204629249131.shtml",
    "datetime": "2020-04-09 20:46:00",
    "code": "300026"
  },
  {
    "title": "红日药业：公司产品血必净注射液列入新冠肺炎诊疗方案（试行第七版）",
    "href": "http://stock.jrj.com.cn/2020/03/05170928959841.shtml",
    "datetime": "2020-03-05 17:09:00",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净注射液列入新冠肺炎诊疗方案第七版",
    "href": "http://stock.jrj.com.cn/2020/03/05170328959815.shtml",
    "datetime": "2020-03-05 17:03:36",
    "code": "300026"
  },
  {
    "title": "红日药业：盐酸莫西沙星氯化钠注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/03/02172728935357.shtml",
    "datetime": "2020-03-02 17:27:00",
    "code": "300026"
  },
  {
    "title": "红日药业2019年度盈利4.06亿增长92% 医疗器械销售增长",
    "href": "http://stock.jrj.com.cn/2020/02/28172228915563.shtml",
    "datetime": "2020-02-28 17:22:23",
    "code": "300026"
  },
  {
    "title": "红日药业为全资子公司北京康仁堂2.5亿元贷款提供担保",
    "href": "http://stock.jrj.com.cn/2020/02/25220028892652.shtml",
    "datetime": "2020-02-25 22:00:08",
    "code": "300026"
  },
  {
    "title": "红日药业：产品供货超千家医院产能正常力保抗疫需求",
    "href": "http://stock.jrj.com.cn/2020/02/22014128874166.shtml",
    "datetime": "2020-02-22 01:41:11",
    "code": "300026"
  },
  {
    "title": "【微访谈精华回顾】红日药业：全力打造中医药全产业链 血必净生产能满足疫情治疗需求",
    "href": "http://stock.jrj.com.cn/2020/02/21194628873123.shtml",
    "datetime": "2020-02-21 19:46:00",
    "code": "300026"
  },
  {
    "title": "红日药业姚小青：全力打造中医药全产业链 血必净生产满足疫情治疗需求",
    "href": "http://stock.jrj.com.cn/2020/02/21171828872077.shtml",
    "datetime": "2020-02-21 17:18:00",
    "code": "300026"
  },
  {
    "title": "红日药业：采购血必净注射液用于新冠肺炎治疗的定点医院超过1000家",
    "href": "http://stock.jrj.com.cn/2020/02/21151428871323.shtml",
    "datetime": "2020-02-21 15:14:00",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净产能已达到正常生产状态 可以满足疫情需求",
    "href": "http://stock.jrj.com.cn/2020/02/21150228871124.shtml",
    "datetime": "2020-02-21 15:02:00",
    "code": "300026"
  },
  {
    "title": "红日药业：将加大力度开拓连锁中医馆领域",
    "href": "http://stock.jrj.com.cn/2020/02/21144828871022.shtml",
    "datetime": "2020-02-21 14:48:00",
    "code": "300026"
  },
  {
    "title": "红日药业：为保持脓毒症治疗领先优势 两个一类新药今年将展开临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/21144228870989.shtml",
    "datetime": "2020-02-21 14:42:00",
    "code": "300026"
  },
  {
    "title": "红日药业：公司在研产品将陆续上市销售",
    "href": "http://stock.jrj.com.cn/2020/02/21143628870966.shtml",
    "datetime": "2020-02-21 14:36:00",
    "code": "300026"
  },
  {
    "title": "红日药业：积极推进全产业链布局",
    "href": "http://stock.jrj.com.cn/2020/02/21142328870902.shtml",
    "datetime": "2020-02-21 14:23:00",
    "code": "300026"
  },
  {
    "title": "【e公司微访谈直播】红日药业：全力打造中医药全产业链 血必净生产能满足疫情需求",
    "href": "http://stock.jrj.com.cn/2020/02/21140928870834.shtml",
    "datetime": "2020-02-21 14:09:00",
    "code": "300026"
  },
  {
    "title": "【e公司微访谈】红日药业：疫情发展对公司生产经营以及复工带来哪些影响？",
    "href": "http://stock.jrj.com.cn/2020/02/21113328870278.shtml",
    "datetime": "2020-02-21 11:33:00",
    "code": "300026"
  },
  {
    "title": "午间公告集锦：红日药业血必净注射液列入新冠肺炎推荐用药",
    "href": "http://stock.jrj.com.cn/2020/02/20121328861447.shtml",
    "datetime": "2020-02-20 12:13:46",
    "code": "300026"
  },
  {
    "title": "午间公告：红日药业血必净注射液列入新冠肺炎推荐用药",
    "href": "http://stock.jrj.com.cn/2020/02/20115728861400.shtml",
    "datetime": "2020-02-20 11:57:00",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净注射液对经营业绩的影响暂无法估计",
    "href": "http://stock.jrj.com.cn/2020/02/19104828853771.shtml",
    "datetime": "2020-02-19 10:48:19",
    "code": "300026"
  },
  {
    "title": "[互动]红日药业：多地子公司都已恢复生产",
    "href": "http://stock.jrj.com.cn/2020/02/14210428831438.shtml",
    "datetime": "2020-02-14 21:04:29",
    "code": "300026"
  },
  {
    "title": "午间公告：红日药业产品列入新冠肺炎诊疗方案 新乳业、仙坛股份回应疫情影响",
    "href": "http://stock.jrj.com.cn/2020/02/06115728783057.shtml",
    "datetime": "2020-02-06 11:57:00",
    "code": "300026"
  },
  {
    "title": "午间公告：红日药业产品列入新冠肺炎诊疗方案",
    "href": "http://stock.jrj.com.cn/2020/02/06115528783052.shtml",
    "datetime": "2020-02-06 11:55:38",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净列入新型冠状病毒感染的肺炎诊疗方案推荐用药",
    "href": "http://stock.jrj.com.cn/2020/02/06115028783058.shtml",
    "datetime": "2020-02-06 11:50:00",
    "code": "300026"
  },
  {
    "title": "红日药业：血必净注射液2018年销售收入占比为22.07%",
    "href": "http://stock.jrj.com.cn/2020/02/05141128775741.shtml",
    "datetime": "2020-02-05 14:11:00",
    "code": "300026"
  },
  {
    "title": "红日药业：主力产品血必净注射液已被多家医院用于新型肺炎治疗",
    "href": "http://stock.jrj.com.cn/2020/02/05103328774430.shtml",
    "datetime": "2020-02-05 10:33:00",
    "code": "300026"
  },
  {
    "title": "红日药业：抗击疫情火线驰援 多维度快速出击",
    "href": "http://stock.jrj.com.cn/2020/01/29203328741782.shtml",
    "datetime": "2020-01-29 20:33:00",
    "code": "300026"
  },
  {
    "title": "红日药业捐赠治疗一线必备物资 为抗冠状病毒作贡献",
    "href": "http://stock.jrj.com.cn/2020/01/26184528736608.shtml",
    "datetime": "2020-01-26 18:45:00",
    "code": "300026"
  },
  {
    "title": "红日药业：2019年度净利同比预增80%-110%",
    "href": "http://stock.jrj.com.cn/2020/01/21174028714108.shtml",
    "datetime": "2020-01-21 17:40:11",
    "code": "300026"
  },
  {
    "title": "红日药业预计2019年盈利3.79亿元至4.43亿元 同比增长80%至110%",
    "href": "http://stock.jrj.com.cn/2020/01/21173428714086.shtml",
    "datetime": "2020-01-21 17:34:13",
    "code": "300026"
  },
  {
    "title": "红日药业：2019年净利同比预增80%-110%",
    "href": "http://stock.jrj.com.cn/2020/01/21172328714018.shtml",
    "datetime": "2020-01-21 17:23:00",
    "code": "300026"
  },
  {
    "title": "红日药业股东陈瑞强减持12万股 套现约41万元",
    "href": "http://stock.jrj.com.cn/2019/12/31224128612629.shtml",
    "datetime": "2019-12-31 22:41:02",
    "code": "300026"
  },
  {
    "title": "红日药业全资子公司北京康仁堂及其控股公司佛慈红日为佛慈制药提供担保",
    "href": "http://stock.jrj.com.cn/2019/12/25224928587182.shtml",
    "datetime": "2019-12-25 22:49:04",
    "code": "300026"
  },
  {
    "title": "红日药业控股子公司原料药通过CDE技术审评审批",
    "href": "http://stock.jrj.com.cn/2019/12/25223928587054.shtml",
    "datetime": "2019-12-25 22:39:40",
    "code": "300026"
  },
  {
    "title": "红日药业：控股子公司依诺肝素钠原料药通过药审中心技术审评",
    "href": "http://stock.jrj.com.cn/2019/12/25184128585935.shtml",
    "datetime": "2019-12-25 18:41:21",
    "code": "300026"
  },
  {
    "title": "红日药业：子公司原料药通过CDE技术审评审批",
    "href": "http://stock.jrj.com.cn/2019/12/25171928585877.shtml",
    "datetime": "2019-12-25 17:19:00",
    "code": "300026"
  },
  {
    "title": "红日药业：控股子公司原料药通过CDE技术审评审批",
    "href": "http://stock.jrj.com.cn/2019/12/25171828585643.shtml",
    "datetime": "2019-12-25 17:18:23",
    "code": "300026"
  },
  {
    "title": "7个月内增持红日药业6%股份 成都兴城集团稳固控制权",
    "href": "http://stock.jrj.com.cn/2019/12/09225528510757.shtml",
    "datetime": "2019-12-09 22:55:14",
    "code": "300026"
  },
  {
    "title": "红日药业：控股股东增持公司股份比例达6%",
    "href": "http://stock.jrj.com.cn/2019/12/09161928508608.shtml",
    "datetime": "2019-12-09 16:19:20",
    "code": "300026"
  },
  {
    "title": "红日药业：控股股东累计增持公司6%股份",
    "href": "http://stock.jrj.com.cn/2019/12/09161128508552.shtml",
    "datetime": "2019-12-09 16:11:08",
    "code": "300026"
  },
  {
    "title": "红日药业：11个产品纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28164328463741.shtml",
    "datetime": "2019-11-28 16:43:27",
    "code": "300026"
  },
  {
    "title": "成都国资继续增持红日药业 拥有表决权比例超27%",
    "href": "http://stock.jrj.com.cn/2019/11/19205528421690.shtml",
    "datetime": "2019-11-19 20:55:00",
    "code": "300026"
  },
  {
    "title": "红日药业：创新药艾姆地芬片获准开展临床试验",
    "href": "http://stock.jrj.com.cn/2019/11/14165728399881.shtml",
    "datetime": "2019-11-14 16:57:33",
    "code": "300026"
  },
  {
    "title": "红日药业：化药1类创新药艾姆地芬片获临床试验批件",
    "href": "http://stock.jrj.com.cn/2019/11/14163228399763.shtml",
    "datetime": "2019-11-14 16:32:00",
    "code": "300026"
  },
  {
    "title": "红日药业第三季度盈利1.66亿 同比增长41%",
    "href": "http://stock.jrj.com.cn/2019/10/29092028315947.shtml",
    "datetime": "2019-10-29 09:20:53",
    "code": "300026"
  },
  {
    "title": "红日药业注销中药饮片《药品GMP》证书",
    "href": "http://stock.jrj.com.cn/2019/10/26084228303461.shtml",
    "datetime": "2019-10-26 08:42:10",
    "code": "300026"
  },
  {
    "title": "红日药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/15022028246133.shtml",
    "datetime": "2019-10-15 02:20:00",
    "code": "300026"
  },
  {
    "title": "红日药业2019年前三季度净利约4.86亿元—5.56亿元",
    "href": "http://stock.jrj.com.cn/2019/10/14185728244592.shtml",
    "datetime": "2019-10-14 18:57:12",
    "code": "300026"
  },
  {
    "title": "红日药业：股东增持4%股份",
    "href": "http://stock.jrj.com.cn/2019/09/20174028160293.shtml",
    "datetime": "2019-09-20 17:40:06",
    "code": "300026"
  },
  {
    "title": "红日药业：获兴城集团累计增持4.04% 拟继续增持",
    "href": "http://stock.jrj.com.cn/2019/09/20171028160177.shtml",
    "datetime": "2019-09-20 17:10:57",
    "code": "300026"
  },
  {
    "title": "红日药业：兴城集团增持比例达4% 未来将继续增持",
    "href": "http://stock.jrj.com.cn/2019/09/20171028160470.shtml",
    "datetime": "2019-09-20 17:10:00",
    "code": "300026"
  },
  {
    "title": "红日药业：大通集团再次质押3200万股，以补充流动性资金",
    "href": "http://stock.jrj.com.cn/2019/09/04163828088942.shtml",
    "datetime": "2019-09-04 16:38:14",
    "code": "300026"
  },
  {
    "title": "红日药业收到《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/09/03083728081224.shtml",
    "datetime": "2019-09-03 08:37:07",
    "code": "300026"
  },
  {
    "title": "红日药业：获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/09/02165028076763.shtml",
    "datetime": "2019-09-02 16:50:06",
    "code": "300026"
  },
  {
    "title": "红日药业2019年上半年净利3.5亿 正在开发清咽利喉、降脂、提高免疫力的颗粒食品产品",
    "href": "http://stock.jrj.com.cn/2019/08/27000028036600.shtml",
    "datetime": "2019-08-27 00:00:47",
    "code": "300026"
  },
  {
    "title": "红日药业收到药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/08/16135927987366.shtml",
    "datetime": "2019-08-16 13:59:29",
    "code": "300026"
  },
  {
    "title": "红日药业复方电解质注射液(Ⅱ)获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/08/16121727986834.shtml",
    "datetime": "2019-08-16 12:17:10",
    "code": "300026"
  },
  {
    "title": "午间公告：红日药业获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/08/16120327986799.shtml",
    "datetime": "2019-08-16 12:03:12",
    "code": "300026"
  },
  {
    "title": "午间公告：红日药业获药品注册批件；硕贝德董事减持股份",
    "href": "http://stock.jrj.com.cn/2019/08/16115827986774.shtml",
    "datetime": "2019-08-16 11:58:00",
    "code": "300026"
  },
  {
    "title": "红日药业股东大通集团解除质押1602万股",
    "href": "http://stock.jrj.com.cn/2019/08/14165027976008.shtml",
    "datetime": "2019-08-14 16:50:23",
    "code": "300026"
  },
  {
    "title": "红日药业股东大通集团解除质押7082万股 新增质押7082万股",
    "href": "http://stock.jrj.com.cn/2019/08/08181527948539.shtml",
    "datetime": "2019-08-08 18:15:20",
    "code": "300026"
  },
  {
    "title": "红日药业累计支付1.17亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/08/05145027930499.shtml",
    "datetime": "2019-08-05 14:50:32",
    "code": "300026"
  },
  {
    "title": "红日药业：股东兴城集团增持公司3.033％股份",
    "href": "http://stock.jrj.com.cn/2019/07/24214327883301.shtml",
    "datetime": "2019-07-24 21:43:59",
    "code": "300026"
  },
  {
    "title": "红日药业2019年上半年净利3.5亿-3.8亿 主力产品销量稳步增长",
    "href": "http://stock.jrj.com.cn/2019/07/12184927833348.shtml",
    "datetime": "2019-07-12 18:49:19",
    "code": "300026"
  },
  {
    "title": "业绩预告与年报净利润差额超2亿 红日药业收监管函",
    "href": "http://stock.jrj.com.cn/2019/07/04214727798598.shtml",
    "datetime": "2019-07-04 21:47:29",
    "code": "300026"
  },
  {
    "title": "红日药业年报信批违规收深交所监管函 实际净利较业绩预告减半",
    "href": "http://stock.jrj.com.cn/2019/07/04194127798226.shtml",
    "datetime": "2019-07-04 19:41:59",
    "code": "300026"
  },
  {
    "title": "红日药业股东兴城集团质押2.44亿股 公司去年净利同比下滑53%",
    "href": "http://stock.jrj.com.cn/2019/06/26080827756714.shtml",
    "datetime": "2019-06-26 08:08:52",
    "code": "300026"
  },
  {
    "title": "红日药业股东兴城集团增持3011万股 耗资9970万元",
    "href": "http://stock.jrj.com.cn/2019/05/22073627605422.shtml",
    "datetime": "2019-05-22 07:36:08",
    "code": "300026"
  },
  {
    "title": "红日药业净利降逾5成股东套现25亿 兴城集团入主首份业绩疲软",
    "href": "http://stock.jrj.com.cn/2019/04/05092327324992.shtml",
    "datetime": "2019-04-05 09:23:38",
    "code": "300026"
  },
  {
    "title": "红日药业去年净利2.11亿元 同比下滑53% 董事长姚小青年薪222万元",
    "href": "http://stock.jrj.com.cn/2019/04/04075927318807.shtml",
    "datetime": "2019-04-04 07:59:22",
    "code": "300026"
  },
  {
    "title": "红日药业净利降逾五成 兴城集团入主首份业绩疲软",
    "href": "http://stock.jrj.com.cn/2019/04/04071827318518.shtml",
    "datetime": "2019-04-04 07:18:06",
    "code": "300026"
  },
  {
    "title": "红日药业2018年增收不增利 2.81亿商誉减值损失侵蚀业绩",
    "href": "http://stock.jrj.com.cn/2019/04/03122527313481.shtml",
    "datetime": "2019-04-03 12:25:35",
    "code": "300026"
  },
  {
    "title": "红日药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/02221027309821.shtml",
    "datetime": "2019-04-02 22:10:00",
    "code": "300026"
  },
  {
    "title": "红日药业：一季度预计盈利1.67亿-1.83亿元",
    "href": "http://stock.jrj.com.cn/2019/04/02202327309370.shtml",
    "datetime": "2019-04-02 20:23:41",
    "code": "300026"
  },
  {
    "title": "红日药业：2018年净利润2.1亿元 同比下降53%",
    "href": "http://stock.jrj.com.cn/2019/04/02202227309368.shtml",
    "datetime": "2019-04-02 20:22:17",
    "code": "300026"
  },
  {
    "title": "[天眼]红日药业易主被问一致行动关系 成都国资委将实控",
    "href": "http://stock.jrj.com.cn/2019/01/23140326946758.shtml",
    "datetime": "2019-01-23 14:03:00",
    "code": "300026"
  },
  {
    "title": "红日药业：成都市国资委将成为公司实际控制人",
    "href": "http://stock.jrj.com.cn/2019/01/21202726937384.shtml",
    "datetime": "2019-01-21 20:27:12",
    "code": "300026"
  },
  {
    "title": "红日药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/14184026902437.shtml",
    "datetime": "2019-01-14 18:40:03",
    "code": "300026"
  },
  {
    "title": "红日药业：已累计回购1.03%股份 耗资1.05亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/07080026864155.shtml",
    "datetime": "2019-01-07 08:00:00",
    "code": "300026"
  },
  {
    "title": "国资上位大股东 红日药业控制权归属存疑",
    "href": "http://stock.jrj.com.cn/2018/12/18083126757905.shtml",
    "datetime": "2018-12-18 08:31:38",
    "code": "300026"
  },
  {
    "title": "红日药业：重大资产重组之限售股份上市流通提示性公告",
    "href": "http://stock.jrj.com.cn/2018/12/11211025544165.shtml",
    "datetime": "2018-12-11 21:10:00",
    "code": "300026"
  },
  {
    "title": "兴城集团进场 红日药业能否挽救颓势？",
    "href": "http://stock.jrj.com.cn/2018/11/30003525423216.shtml",
    "datetime": "2018-11-30 00:35:26",
    "code": "300026"
  },
  {
    "title": "[红日药业]张国清市长主持召开生物医药领域部分企业和科研机构座谈会",
    "href": "http://stock.jrj.com.cn/2018/11/28000025420328.shtml",
    "datetime": "2018-11-28 00:00:00",
    "code": "300026"
  },
  {
    "title": "红日药业：成都兴城集团拟受让逾16%公司股份",
    "href": "http://stock.jrj.com.cn/2018/11/26203925410620.shtml",
    "datetime": "2018-11-26 20:39:37",
    "code": "300026"
  },
  {
    "title": "红日药业：首次回购150万股 耗资512万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/16080025355606.shtml",
    "datetime": "2018-11-16 08:00:00",
    "code": "300026"
  },
  {
    "title": "红日药业：首次回购150万股",
    "href": "http://stock.jrj.com.cn/2018/11/15183325350793.shtml",
    "datetime": "2018-11-15 18:33:00",
    "code": "300026"
  },
  {
    "title": "医药送礼清单敲诈300万！A股最奇葩勒索:用比特币支付",
    "href": "http://stock.jrj.com.cn/2018/11/06222025312152.shtml",
    "datetime": "2018-11-06 22:20:02",
    "code": "300026"
  },
  {
    "title": "男子勒索红日药业2099枚比特币 却只换来200多万",
    "href": "http://stock.jrj.com.cn/2018/11/06220825312135.shtml",
    "datetime": "2018-11-06 22:08:58",
    "code": "300026"
  },
  {
    "title": "3年前被敲诈两千多个比特币 红日药业回应称涉及企业安全",
    "href": "http://stock.jrj.com.cn/2018/11/06161925310968.shtml",
    "datetime": "2018-11-06 16:19:36",
    "code": "300026"
  },
  {
    "title": "红日药业：拟斥资0.6亿元-2亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/18080025104661.shtml",
    "datetime": "2018-09-18 08:00:02",
    "code": "300026"
  },
  {
    "title": "红日药业：拟6000万至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/09/17184025102183.shtml",
    "datetime": "2018-09-17 18:40:00",
    "code": "300026"
  },
  {
    "title": "红日药业拟不超过2亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2018/09/17182825102104.shtml",
    "datetime": "2018-09-17 18:28:22",
    "code": "300026"
  },
  {
    "title": "红日药业等三公司回购公司股份",
    "href": "http://stock.jrj.com.cn/2018/09/17182725102100.shtml",
    "datetime": "2018-09-17 18:27:04",
    "code": "300026"
  },
  {
    "title": "中药注射液行业业绩分化？ 业内人士称下滑大趋势不变",
    "href": "http://stock.jrj.com.cn/2018/08/24005924993783.shtml",
    "datetime": "2018-08-24 00:59:01",
    "code": "300026"
  },
  {
    "title": "[红日药业]综合资讯",
    "href": "http://stock.jrj.com.cn/2018/08/21000024979086.shtml",
    "datetime": "2018-08-21 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业中药配方颗粒宜阳项目顺利签约",
    "href": "http://stock.jrj.com.cn/2018/08/14000024950305.shtml",
    "datetime": "2018-08-14 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业中药配方颗粒宜阳项目顺利签约",
    "href": "http://stock.jrj.com.cn/2018/08/09000024929876.shtml",
    "datetime": "2018-08-09 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]综合资讯",
    "href": "http://stock.jrj.com.cn/2018/07/20000024840711.shtml",
    "datetime": "2018-07-20 00:00:00",
    "code": "300026"
  },
  {
    "title": "红日药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/13133024812612.shtml",
    "datetime": "2018-07-13 13:30:00",
    "code": "300026"
  },
  {
    "title": "[佛慈制药]佛慈制药和红日药业强强联合共谋中医药发展",
    "href": "http://stock.jrj.com.cn/2018/07/13000024826741.shtml",
    "datetime": "2018-07-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "创始人姚小青上位实控人 红日药业控股权峰回路转",
    "href": "http://stock.jrj.com.cn/2018/06/26054324726265.shtml",
    "datetime": "2018-06-26 05:43:49",
    "code": "300026"
  },
  {
    "title": "大股东拟出让股权 红日药业控制权骤变之谜",
    "href": "http://stock.jrj.com.cn/2018/06/19044624693103.shtml",
    "datetime": "2018-06-19 04:46:30",
    "code": "300026"
  },
  {
    "title": "红日药业控股股东质押7529.41万股 补充流动性资金",
    "href": "http://stock.jrj.com.cn/2018/06/12125524668603.shtml",
    "datetime": "2018-06-12 12:55:00",
    "code": "300026"
  },
  {
    "title": "天津大通集团瘦身之谜",
    "href": "http://stock.jrj.com.cn/2018/06/12085624667272.shtml",
    "datetime": "2018-06-12 08:56:41",
    "code": "300026"
  },
  {
    "title": "红日药业：复牌公告",
    "href": "http://stock.jrj.com.cn/2018/06/08214024657339.shtml",
    "datetime": "2018-06-08 21:40:00",
    "code": "300026"
  },
  {
    "title": "红日药业控股股东转让10%股份 实控人认定存不确定性",
    "href": "http://stock.jrj.com.cn/2018/06/08205724657219.shtml",
    "datetime": "2018-06-08 20:57:39",
    "code": "300026"
  },
  {
    "title": "红日药业：控股股东转让10%股权 实控人认定存不确定性",
    "href": "http://stock.jrj.com.cn/2018/06/08201524657133.shtml",
    "datetime": "2018-06-08 20:15:00",
    "code": "300026"
  },
  {
    "title": "红日药业：控股股东筹划股权转让 实控人或变更",
    "href": "http://stock.jrj.com.cn/2018/06/06182524646748.shtml",
    "datetime": "2018-06-06 18:25:00",
    "code": "300026"
  },
  {
    "title": "红日药业控股股东筹划股权转让事项 或涉及实控人变更",
    "href": "http://stock.jrj.com.cn/2018/06/06180024646693.shtml",
    "datetime": "2018-06-06 18:00:17",
    "code": "300026"
  },
  {
    "title": "红日药业等3股今日临停",
    "href": "http://stock.jrj.com.cn/2018/06/06091324643944.shtml",
    "datetime": "2018-06-06 09:13:40",
    "code": "300026"
  },
  {
    "title": "[红日药业]向世界展示中国魅力 红日药业亮相首届品博会",
    "href": "http://stock.jrj.com.cn/2018/06/06000026839342.shtml",
    "datetime": "2018-06-06 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]广州医珍堂匠心独运 打造中医健康新生活",
    "href": "http://stock.jrj.com.cn/2018/06/06000026839343.shtml",
    "datetime": "2018-06-06 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]综合资讯",
    "href": "http://stock.jrj.com.cn/2018/05/25000024591009.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]提升内力 砥砺奋斗 天津红日康仁堂药品销售有限公司湖南分公司举办综合能力培训",
    "href": "http://stock.jrj.com.cn/2018/05/15000026839341.shtml",
    "datetime": "2018-05-15 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]超思惊艳登场CMEF 助力“医疗数字化”进程",
    "href": "http://stock.jrj.com.cn/2018/05/02000024480522.shtml",
    "datetime": "2018-05-02 00:00:00",
    "code": "300026"
  },
  {
    "title": "红日药业：中医药及医疗器械市场将迎来前所未有的发展机遇",
    "href": "http://stock.jrj.com.cn/2018/04/10184524369574.shtml",
    "datetime": "2018-04-10 18:45:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]中药配方颗粒项目落户秀山",
    "href": "http://stock.jrj.com.cn/2018/04/02000024338655.shtml",
    "datetime": "2018-04-02 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]北京康仁堂通过“北京医药行业中药材标准化基地-白芍基地”认证",
    "href": "http://stock.jrj.com.cn/2018/04/02000024338653.shtml",
    "datetime": "2018-04-02 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]长春中医药大学与北京康仁堂药业有限公司签订校企科研合作协议",
    "href": "http://stock.jrj.com.cn/2018/04/02000024338654.shtml",
    "datetime": "2018-04-02 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]北京康仁堂荣获“2017年度北京市科学技术奖”一等奖",
    "href": "http://stock.jrj.com.cn/2018/03/27000024305220.shtml",
    "datetime": "2018-03-27 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]北京康仁堂荣获“2017年度北京市诚信创建企业”称号",
    "href": "http://stock.jrj.com.cn/2018/02/12000024105985.shtml",
    "datetime": "2018-02-12 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业收购海南龙圣堂制药有限公司100%股权",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975371.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业获评2016最具科技创新力中药企业",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975383.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业2014全国医药工业百强排行榜排名大幅提升",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975387.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业获评2016年国家技术创新示范企业",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975365.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业荣获第十二届“金圆桌”优秀董事会奖",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975369.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业当选为安全生产管理协会理事单位",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975374.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]中国医药行业“最具影响力”榜单揭晓,红日药业斩获两项殊荣",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975372.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]第八届中国医药上市公司竞争力20强评选 红日药业再获殊荣",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975396.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业荣获上市公司2014年度金牛最佳创业成长公司等殊荣",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975378.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]国家企业技术中心评选揭晓 红日药业首获国家级创新平台",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975370.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]战略引领 卓越品质 · 品牌提升铸辉煌",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975398.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]心系塘沽 红日在行动系列活动之二",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975392.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]弘扬民族医药 打造民族品牌 北京康仁堂荣获“2016年度中华民族医药百强品牌企业”称号",
    "href": "http://stock.jrj.com.cn/2017/12/13000023975395.shtml",
    "datetime": "2017-12-13 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业荣获天津市第二届质量奖",
    "href": "http://stock.jrj.com.cn/2017/12/08000023975397.shtml",
    "datetime": "2017-12-08 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业荣获猎聘网天津2017年度“非凡雇主”大奖",
    "href": "http://stock.jrj.com.cn/2017/12/08000023975361.shtml",
    "datetime": "2017-12-08 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日员工活动又添好去处 红日药业职工活动中心揭牌仪式举办",
    "href": "http://stock.jrj.com.cn/2017/12/08000023975347.shtml",
    "datetime": "2017-12-08 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]超思隆重亮相全球最大医疗设备展会-MEDICA",
    "href": "http://stock.jrj.com.cn/2017/12/08000023975356.shtml",
    "datetime": "2017-12-08 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]河南中医药大学、红日药业中医药战略合作框架协议签订 暨“康仁堂”基金捐赠仪式成功举办",
    "href": "http://stock.jrj.com.cn/2017/12/08000023975352.shtml",
    "datetime": "2017-12-08 00:00:00",
    "code": "300026"
  },
  {
    "title": "[红日药业]红日药业荣获“创业板上市公司价值二十强”等三项大奖",
    "href": "http://stock.jrj.com.cn/2017/11/23000023975368.shtml",
    "datetime": "2017-11-23 00:00:00",
    "code": "300026"
  },
  {
    "title": "红日药业：对甲苯磺酰胺生产注册申请已被正式受理",
    "href": "http://stock.jrj.com.cn/2017/07/04191122696831.shtml",
    "datetime": "2017-07-04 19:11:00",
    "code": "300026"
  },
  {
    "title": "红日药业：取得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2016/11/14080021701858.shtml",
    "datetime": "2016-11-14 08:00:00",
    "code": "300026"
  },
  {
    "title": "红日药业半年报推10转20 股权登记日10月25日",
    "href": "http://stock.jrj.com.cn/2016/10/19170021592124.shtml",
    "datetime": "2016-10-19 17:00:32",
    "code": "300026"
  },
  {
    "title": "[互动]红日药业：10月17审议半年度利润分配预案",
    "href": "http://stock.jrj.com.cn/2016/10/08082821541984.shtml",
    "datetime": "2016-10-08 08:28:50",
    "code": "300026"
  },
  {
    "title": "红日药业拟5000万元参与投资设立产业投资基金",
    "href": "http://stock.jrj.com.cn/2016/07/04221321149171.shtml",
    "datetime": "2016-07-04 22:13:30",
    "code": "300026"
  },
  {
    "title": "基药增补招投标：红日药业独家产品“掘金”涉嫌违规",
    "href": "http://stock.jrj.com.cn/2014/04/01025816961194.shtml",
    "datetime": "2014-04-01 02:58:00",
    "code": "300026"
  },
  {
    "title": "红日药业2013年业绩同比预增逾三成",
    "href": "http://stock.jrj.com.cn/2014/01/14170216505290.shtml",
    "datetime": "2014-01-14 17:02:49",
    "code": "300026"
  },
  {
    "title": "红日药业推900万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2013/11/22183316202981.shtml",
    "datetime": "2013-11-22 18:33:00",
    "code": "300026"
  },
  {
    "title": "红日药业投10亿建产业基地 资金紧张拉高管入伙",
    "href": "http://stock.jrj.com.cn/2013/10/09024015927105.shtml",
    "datetime": "2013-10-09 02:40:42",
    "code": "300026"
  },
  {
    "title": "红日药业研发中心项目部分工程延期",
    "href": "http://stock.jrj.com.cn/2013/08/29121615758202.shtml",
    "datetime": "2013-08-29 12:16:25",
    "code": "300026"
  },
  {
    "title": "红日药业大股东质押所持1250万股股权",
    "href": "http://stock.jrj.com.cn/2013/08/12122615667041.shtml",
    "datetime": "2013-08-12 12:26:40",
    "code": "300026"
  },
  {
    "title": "7月创业板高管套现近10亿 红日药业高管套现过亿",
    "href": "http://stock.jrj.com.cn/2013/08/06153415641451.shtml",
    "datetime": "2013-08-06 15:34:27",
    "code": "300026"
  },
  {
    "title": "红日药业董事长踩点减持2.1亿元 疑中报变脸",
    "href": "http://stock.jrj.com.cn/2013/07/05141215488784.shtml",
    "datetime": "2013-07-05 14:12:21",
    "code": "300026"
  },
  {
    "title": "红日药业一中药生产基地延期投产",
    "href": "http://stock.jrj.com.cn/2013/05/27214315341555.shtml",
    "datetime": "2013-05-27 21:43:51",
    "code": "300026"
  },
  {
    "title": "红日药业血必净大楼通过新版GMP认证",
    "href": "http://stock.jrj.com.cn/2013/03/21173215163607.shtml",
    "datetime": "2013-03-21 17:32:59",
    "code": "300026"
  },
  {
    "title": "红日药业：对康仁堂3000万元贷款展期",
    "href": "http://stock.jrj.com.cn/hotstock/2013/01/21093514967607.shtml",
    "datetime": "2013-01-21 09:35:00",
    "code": "300026"
  },
  {
    "title": "红日药业：业绩符合预期 2013年看产能释放",
    "href": "http://stock.jrj.com.cn/hotstock/2013/01/08133414915875.shtml",
    "datetime": "2013-01-08 13:34:00",
    "code": "300026"
  },
  {
    "title": "红日药业强渠道保障业绩",
    "href": "http://stock.jrj.com.cn/hotstock/2012/11/16093714685853.shtml",
    "datetime": "2012-11-16 09:37:53",
    "code": "300026"
  },
  {
    "title": "红日药业：定增落定 新增股东值得关注",
    "href": "http://stock.jrj.com.cn/hotstock/2012/11/15170214682401.shtml",
    "datetime": "2012-11-15 17:02:22",
    "code": "300026"
  },
  {
    "title": "红日药业 两大产品带动增长",
    "href": "http://stock.jrj.com.cn/hotstock/2012/11/09110814651260.shtml",
    "datetime": "2012-11-09 11:08:11",
    "code": "300026"
  },
  {
    "title": "红日药业:业绩超预期 维持“强烈推荐”",
    "href": "http://stock.jrj.com.cn/hotstock/2012/10/24125414562600.shtml",
    "datetime": "2012-10-24 12:54:28",
    "code": "300026"
  },
  {
    "title": "红日药业：收购康仁堂少数股东权益将增厚业绩",
    "href": "http://stock.jrj.com.cn/hotstock/2012/10/12132014505084.shtml",
    "datetime": "2012-10-12 13:20:58",
    "code": "300026"
  },
  {
    "title": "红日药业被指瞒报供应商造假",
    "href": "http://stock.jrj.com.cn/2012/09/25070914434900.shtml",
    "datetime": "2012-09-25 07:09:23",
    "code": "300026"
  },
  {
    "title": "红日药业:亮丽中报 继续推荐",
    "href": "http://stock.jrj.com.cn/hotstock/2012/08/14133614131780.shtml",
    "datetime": "2012-08-14 13:36:18",
    "code": "300026"
  },
  {
    "title": "红日药业上半年净利暴增150% 两产品成增长极",
    "href": "http://stock.jrj.com.cn/2012/08/04105314019515.shtml",
    "datetime": "2012-08-04 10:53:52",
    "code": "300026"
  },
  {
    "title": "红日药业：中报远超预期 给予“买入”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2012/08/03072814006724.shtml",
    "datetime": "2012-08-03 07:28:52",
    "code": "300026"
  },
  {
    "title": "红日药业：营业收入超出预期 “增持”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2012/08/03050214004691.shtml",
    "datetime": "2012-08-03 05:02:46",
    "code": "300026"
  }
]